提醒成功
搜索
| 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody |
| Host | CHO cells |
| catalog# | B00069 |
| Application | Flow cytometry, animal model study |
| Aliases | Folate Receptor alpha, Folate Receptor 1, Folate Receptor alpha, Folate Binding Protein, FBP |
| Size/Concentration | 1mg/5mg/20mg |
| Isotype | Human IgG1 kappa |
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Human FOLR1 |
| Formulation | PBS, pH 7.4 |
Description |
|---|
What is Mirvetuximab biosimilar research grade? Mirvetuximab biosimilar uses the same protein sequences as the therapeutic antibody Mirvetuximab. Mirvetuximab soravtansine is used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha (FRa)-directed antibody and microtubule inhibitor conjugate. |
Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody B00069
规格:
- 1mg
- 5mg
- 20mg
数量:
-
+
说明书:
¥2275
-
咨询
-
收藏

微信/QQ登录


首页